{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T22:28:10Z","timestamp":1782167290304,"version":"3.54.5"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T00:00:00Z","timestamp":1676592000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>There is no unified standard data about the sensitivity and specificity regarding flow cytometry analysis of Ki67 expression during lymphoma diagnoses.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>This evaluated the efficacy of multicolor flow cytometry (MFC) in an estimate of the proliferative activity of B-cell non-Hodgkin lymphoma by comparing the expression of Ki67 using MFC and immunohistochemicals (IHC).<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>A total of 559 patients with non-Hodgkin B-cell lymphoma were immunophenotyped using sensitive MFC, of which 517 were newly diagnosed and 42 were transformed lymphomas. Test samples include peripheral blood, bone marrow, various body fluids, and tissues. Through MFC multi-marker accurate gating, abnormal mature B lymphocytes with restricted expression of the light chain were screened. Ki67 was added to determine the proliferation index; the positive rate of Ki67 in tumor B cells was evaluated by cell grouping and internal control. For tissue specimens, MFC and IHC analyses were performed simultaneously to assess the Ki67 proliferation index.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The positive rate of Ki67 by MFC was correlated with the subtype and aggressiveness of B-cell lymphoma. Ki67 could distinguish indolent lymphomas from aggressive subtypes with a cut-off value of 21.25%, and differentiate transformation from indolent lymphoma with a cut-off value of 7.65%. The expression of Ki67 by MFC (regardless of the type of samples)was highly agreement with the Ki67 proliferative index of tissue samples assessed by pathologic immunohistochemistry. MFC showed a fairly constant negative bias in evaluating tissue or bone marrow samples, compared with IHC.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Ki67 is a valuable flow marker that can distinguish between indolent and aggressive types of lymphoma and assess whether indolent lymphomas are transformed. Using MFC to evaluate the positive rate of Ki67 is important in clinical settings. MFC has unique advantages in judging the aggressiveness of lymphoma in samples of bone marrow, peripheral blood, pleural and ascites, and cerebrospinal fluid. This is particularly important when tissue samples cannot be obtained, making it an important supplement for pathologic examination.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2023.1108837","type":"journal-article","created":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T07:51:32Z","timestamp":1676620292000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Multicolor flow cytometric assessment of Ki67 expression and its diagnostic value in mature B-cell neoplasms"],"prefix":"10.3389","volume":"13","author":[{"given":"Xia","family":"Mao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songya","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujuan","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,2,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2-4-235","article-title":"Classification of non-hodgkin's lymphoma: A proposal","volume":"2","author":"Hern\u00e1ndez","year":"1997","journal-title":"Oncologist"},{"key":"B2","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"Swerdlow","year":"2017"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the world health organization classification of haematolymphoid tumours: Lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21406","article-title":"Role and prognostic significance of the ki-67 index in non-hodgkin's lymphoma","volume":"84","author":"Broyde","year":"2009","journal-title":"Am J Hematol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V90.8.2863","article-title":"Recent advances in flow cytometry: Application to the diagnosis of hematologic malignancy","volume":"90","author":"Jennings","year":"1997","journal-title":"Blood"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-11-120535","article-title":"Flow cytometric immunophenotyping for hematologic neoplasms","volume":"111","author":"Craig","year":"2008","journal-title":"Blood"},{"key":"B7","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1309\/X8LB-RRBB-C43P-L9HC","article-title":"The usefulness of CD71 expression by flow cytometry for differentiating indolent from aggressive CD10+ b-cell lymphomas","volume":"126","author":"Wu","year":"2006","journal-title":"Am J Clin Pathol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1309\/AJCP3FEPX5BEEKGX","article-title":"Differentiating between burkitt lymphoma and CD10+ diffuse large b-cell lymphoma: The role of commonly used flow cytometry cell markers and the application of a multiparameter scoring system","volume":"137","author":"McGowan","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9","article-title":"The ki-67 protein: From the known and the unknown","volume":"182","author":"Scholzen","year":"2000","journal-title":"J Cell Physiol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1046\/j.1365-2559.2002.01343.x","article-title":"Ki67 protein: The immaculate deception","volume":"40","author":"Brown","year":"2002","journal-title":"Histopathology"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1006\/excr.2000.4888","article-title":"The ki-67 protein: fascinating forms and an unknown function","volume":"257","author":"Endl","year":"2000","journal-title":"Exp Cell Res"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-01-293050","article-title":"The 2008 WHO classification of lymphoid neoplasms and beyond: Evolving concepts and practical applications","volume":"117","author":"Campo","year":"2011","journal-title":"Blood"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022015851","article-title":"The international consensus classification of mature lymphoid neoplasms: A report from the clinical advisory committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.962428","article-title":"PD-1 combined with TRBC1 and pan-T cell antibodies for robustly monitoring angioimmunoblastic T-cell lymphoma","volume":"9","author":"Wang","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2005.05550.x","article-title":"Diagnostic criteria for monoclonal b-cell lymphocytosis","volume":"130","author":"Marti","year":"2005","journal-title":"Br J Haematol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/path.1711540305","article-title":"The prognostic value of Ki67 immunostaining in non-hodgkin's lymphoma","volume":"154","author":"Hall","year":"1988","journal-title":"J Pathol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1292\/jvms.15-0693","article-title":"Apoptosis and ki-67 as predictive factors for response to radiation therapy in feline nasal lymphomas","volume":"78","author":"Fu","year":"2016","journal-title":"J Vet Med Sci"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/103.5.543","article-title":"A revised European-American classification of lymphoid neoplasms proposed by the international lymphoma study group. a summary version","volume":"103","author":"Chan","year":"1995","journal-title":"Am J Clin Pathol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V83.6.1460.1460","article-title":"Prognostic significance of the ki-67-associated proliferative antigen in aggressive non-hodgkin's lymphomas: A prospective southwest oncology group trial","volume":"83","author":"Miller","year":"1994","journal-title":"Blood"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2184.1993.tb00130.x","article-title":"Proliferating cell nuclear antigen and ki-67 antigen expression in human haematopoietic cells during growth stimulation and differentiation","volume":"26","author":"Landberg","year":"1993","journal-title":"Cell Prolif"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V80.9.2336.bloodjournal8092336","article-title":"Cell cycle kinetics in malignant lymphoma studied with in vivo iododeoxyuridine administration, nuclear ki-67 staining, and flow cytometry","volume":"80","author":"Brons","year":"1992","journal-title":"Blood"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2778","article-title":"Prognostic significance of histologic grade and ki-67 proliferation index in follicular lymphoma","volume":"38","author":"Xue","year":"2020","journal-title":"Hematol Oncol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.20363","article-title":"2006 Bethesda international consensus recommendations on the immunophenotypic analysis of hematolymphoid neoplasia by flow cytometry: Optimal reagents and reporting for the flow cytometric diagnosis of hematopoietic neoplasia","volume":"72","author":"Wood","year":"2007","journal-title":"Cytom B Clin Cytom"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12667","article-title":"Association of quantitative assessment of the intrafollicular proliferation index with outcome in follicular lymphoma","volume":"164","author":"Kedmi","year":"2014","journal-title":"Br J Haematol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.10384","article-title":"The prognostic significance of the intra-follicular tumor cell proliferative rate in follicular lymphoma","volume":"92","author":"Koster","year":"2007","journal-title":"Haematologica"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-06-095331","article-title":"A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma","volume":"111","author":"Hoster","year":"2008","journal-title":"Blood"},{"key":"B27","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1034\/j.1600-0609.2002.01677.x","article-title":"Ki-67 expression level, histological subtype, and the international prognostic index as outcome predictors in mantle cell lymphoma","volume":"69","author":"R\u00e4ty","year":"2002","journal-title":"Eur J Haematol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.63.8387","article-title":"Prognostic value of ki-67 index, cytology, and growth pattern in mantle-cell lymphoma: Results from randomized trials of the European mantle cell lymphoma network","volume":"34","author":"Hoster","year":"2016","journal-title":"J Clin Oncol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s12308-009-0036-x","article-title":"Ki-67 as a prognostic marker in mantle cell lymphoma-consensus guidelines of the pathology panel of the European MCL network","volume":"2","author":"Klapper","year":"2009","journal-title":"J Hematop"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000758","article-title":"Mantle cell lymphoma with MYC rearrangement: A report of 17 patients","volume":"41","author":"Hu","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25487","article-title":"Mantle cell lymphoma: 2019 update on the diagnosis, pathogenesis, prognostication, and management","volume":"94","author":"Jain","year":"2019","journal-title":"Am J Hematol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1827.2004.01678.x","article-title":"Efficacy of rituximab plus chemotherapy in follicular lymphoma depends on ki-67 expression","volume":"54","author":"Saito","year":"2004","journal-title":"Pathol Int"},{"key":"B33","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1097\/00129039-200406000-00001","article-title":"Immunophenotypic and genotypic characterization of progression in follicular lymphomas","volume":"12","author":"Natkunam","year":"2004","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1385\/MO:23:1:83","article-title":"Ki-67 proliferative marker in lymph node aspirates of patients with non-hodgkin's lymphoma","volume":"23","author":"Mihaljevi\u0107","year":"2006","journal-title":"Med Oncol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3109\/02841869109088244","article-title":"Expression of proliferating cell nuclear antigen (PCNA) and ki-67 antigen in human malignant hematopoietic cells","volume":"30","author":"Landberg","year":"1991","journal-title":"Acta Oncol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0021-9975(97)80066-7","article-title":"Growth fractions in canine non-hodgkin's lymphomas as determined in situ by the expression of the ki-67 antigen","volume":"117","author":"Fournel-Fleury","year":"1997","journal-title":"J Comp Pathol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1002\/cncy.20075","article-title":"Classifying b-cell non-Hodgkin lymphoma by using MIB-1 proliferative index in fine-needle aspirates","volume":"118","author":"Ali","year":"2010","journal-title":"Cancer Cytopathol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.55.6.467","article-title":"Comparison of ki-67 equivalent antibodies","volume":"55","author":"Lindboe","year":"2002","journal-title":"J Clin Pathol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1111\/vco.12694","article-title":"Ki-67 assessment-agreeability between immunohistochemistry and flow cytometry in canine lymphoma","volume":"19","author":"Rigillo","year":"2021","journal-title":"Vet Comp Oncol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-01-070300","article-title":"Concordant but not discordant bone marrow involvement in diffuse large b-cell lymphoma predicts a poor clinical outcome independent of the international prognostic index","volume":"110","author":"Chung","year":"2007","journal-title":"Blood"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-06-651968","article-title":"Discordant bone marrow involvement in non-Hodgkin lymphoma","volume":"127","author":"Brudno","year":"2016","journal-title":"Blood"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1108837\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T11:45:49Z","timestamp":1676893549000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1108837\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,17]]},"references-count":41,"alternative-id":["10.3389\/fonc.2023.1108837"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2023.1108837","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,17]]},"article-number":"1108837"}}